Clinical trial NCT00536627 - References

Chronic Hepatitis B — Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis

Citation(s)

•   Mancini-Bourgine M, Fontaine H, Bréchot C, Pol S, Michel ML
  Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006 May 22;24(21):4482-9. Epub 2005 Aug 18.
•   Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Bréchot C, Michel ML
  Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology. 2004 Oct;40(4):874-82.

Randomised, Opened, Multicentre Phase I/II Trial in Patients With Chronic Hepatitis B With HBV VL < 12 IU/ml and Under Treatment With NRTI, Which Evaluated Efficacy and Tolerance of Vaccination With Naked DNA on Viral Replication After Analogs' Treatment Interruption. ANRS HB02 VAC-ADN

Details for clinical trial NCT00536627